REGENERX BIOPHARMACEUTICALS INC Uncategorized Contracts & Agreements
40 Contracts & Agreements
- Letter to Stockholders dated July 10, 2023 (Filed With SEC on July 10, 2023)
- Lock-Up Agreement between Company and various investors dated June 30, 2021 (Filed With SEC on August 6, 2021)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on July 1, 2016)
- RGN-259 U.S. LICENSEAgreement (Filed With SEC on May 15, 2015)
- ExecutiveEMPLOYMENT AGREEMENT (Filed With SEC on August 14, 2014)
- ExecutiveEMPLOYMENT AGREEMENT (Filed With SEC on August 14, 2014)
- ExecutiveEMPLOYMENT AGREEMENT (Filed With SEC on August 14, 2014)
- rgn-137LICENSE Agreement (Filed With SEC on May 15, 2014)
- RGN-259LICENSE Agreement (Filed With SEC on May 15, 2014)
- RegeneRxBiopharmaceuticals, Inc. ·15245 Shady Grove Road, Suite 470, Rockville, MD 20850 PHONE301 ###-###-#### ·FAX ###-###-#### ·WEB www.regenerx.com (Filed With SEC on January 9, 2014)
- RegeneRxBiopharmaceuticals, Inc. ·15245 Shady Grove Road, Suite 470, Rockville, MD 20850 PHONE301 ###-###-#### ·FAX ###-###-#### ·WEB www.regenerx.com (Filed With SEC on January 9, 2014)
- REGENERX BIOPHARMACEUTICALS, INC. (Filed With SEC on September 17, 2013)
- RegeneRxBiopharmaceuticals, Inc. ·15245 Shady Grove Road, Suite 470, Rockville, MD 20850 PHONE301 ###-###-#### ·FAX ###-###-#### ·WEB www.regenerx.com (Filed With SEC on January 8, 2013)
- RegeneRxBiopharmaceuticals, Inc. ·15245 Shady Grove Road, Suite 470, Rockville, MD 20850 PHONE301 ###-###-#### ·FAX ###-###-#### ·WEB www.regenerx.com (Filed With SEC on January 8, 2013)
- RegeneRxBiopharmaceuticals, Inc. ·15245 Shady Grove Road, Suite 470, Rockville, MD 20850 PHONE301 ###-###-#### ·FAX ###-###-#### ·WEB www.regenerx.com (Filed With SEC on January 8, 2013)
- LICENSEAgreement (Filed With SEC on November 14, 2012)
- RegeneRxBiopharmaceuticals, Inc. ·15245 Shady Grove Road, Suite 470, Rockville, MD 20850 PHONE ###-###-#### ·FAX ###-###-#### ·WEB www.regenerx.com (Filed With SEC on August 14, 2012)
- RegeneRxBiopharmaceuticals, Inc. ·15245 Shady Grove Road, Suite 470, Rockville, MD 20850 PHONE ###-###-#### ·FAX ###-###-#### ·WEB www.regenerx.com (Filed With SEC on August 14, 2012)
- RegeneRxBiopharmaceuticals, Inc. · 15245 Shady Grove Road, Suite 470, Rockville, MD 20850 PHONE301 ###-###-#### · FAX ###-###-#### · WEB www.regenerx.com (Filed With SEC on August 14, 2012)
- RegeneRxBiopharmaceuticals, Inc. 15245 Shady Grove Road, Suite 470, Rockville, MD 20850 PHONE ###-###-#### FAX ###-###-#### WEB www.regenerx.com (Filed With SEC on May 15, 2012)
- RegeneRxBiopharmaceuticals, Inc. 15245 Shady Grove Road, Suite 470, Rockville, MD 20850 PHONE ###-###-#### FAX ###-###-#### WEB www.regenerx.com (Filed With SEC on May 15, 2012)
- RegeneRxBiopharmaceuticals, Inc. 15245 Shady Grove Road, Suite 470, Rockville, MD 20850 PHONE ###-###-#### FAX ###-###-#### WEB www.regenerx.com (Filed With SEC on May 15, 2012)
- RegeneRx Biopharmaceuticals, Inc 15245 Shady Grove Road, Suite 470, Rockville, MD20850 PHONE ###-###-#### FAX301 ###-###-#### WEB www.regenerx.com (Filed With SEC on January 6, 2012)
- RegeneRx Biopharmaceuticals, Inc. 15245 Shady Grove Road, Suite 470, Rockville, MD20850 PHONE ###-###-#### FAX301 ###-###-#### WEB www.regenerx.com (Filed With SEC on January 6, 2012)
- RegeneRx Biopharmaceuticals,Inc. 15245 Shady Grove Road, Suite 470, Rockville, MD 20850 PHONE301 ###-###-#### FAX ###-###-#### WEB www.regenerx.com (Filed With SEC on January 6, 2012)
- Void After January 7, 2016 (Filed With SEC on January 7, 2011)
- REGENERX BIOPHARMACEUTICALS, INC. (Filed With SEC on May 21, 2010)
- 11,500,000 UNITS (Filed With SEC on May 21, 2010)
- REGENERX BIOPHARMACEUTICALS, INC. (Filed With SEC on May 17, 2010)
- [] UNITS (Filed With SEC on May 17, 2010)
- AMENDMENT NO. 1 TO RIGHTS AGREEMENT (Filed With SEC on April 16, 2010)
- RIGHTS AGREEMENT (Filed With SEC on April 16, 2010)
- Form of Right Certificate (Filed With SEC on April 16, 2010)
- RGN-137, a topically applied gel for chronic dermal wounds and reduction of scar tissue (Filed With SEC on March 31, 2010)
- REGENERX BIOPHARMACEUTICALS, INC. (Filed With SEC on April 16, 2009)
- RGN-137, a topically applied gel for hard-to-heal chronic dermal wounds (Filed With SEC on April 15, 2009)
- RGN-137, a topically applied gel for hard-to-heal chronic dermal wounds (Filed With SEC on April 15, 2009)
- RGN-137, a topically applied gel for hard-to-heal chronic dermal wounds (Filed With SEC on April 15, 2009)
- RGN-137, a topically applied gel for hard-to-heal chronic dermal wounds (Filed With SEC on April 15, 2009)
- TEN COM as tenants in common UNIF GIFT MIN ACT- _________Custodian _________TEN ENT as tenants by the entireties (Cust) (Minor)JT TEN as joint tenants with right of under Uniform... (Filed With SEC on April 16, 2010)
